Pieris' Secondary Market Round

Pieris raised a round of funding on November 23, 2013. Investors include Sobera Capital.

Pieris is an independent, clinical-staged biotechnology company advancing its proprietary Anticalin technology to create differentiated drugs that are safer and more effective than conventional approa…

Articles about Pieris' Secondary Market Round: